INCY
INCYTE CORP
NASDAQ · Healthcare · Biotechnology · US
$113.25
+0.16%Forward multiples
Based on analyst estimates
- P/E forward
- 14.45x
- P/E 2026E
- 35.13x
- P/E 2027E
- 13.94x
- P/E 2028E
- 12.67x
- P/S forward
- 3.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.93x
- PEG TTM
- 0.22x
- Price / book
- 3.62x
- Price / sales
- 3.94x
- Price / cash flow
- 11.60x
Enterprise value
- Enterprise value
- $18.5B
- EV / sales
- 3.17x
- EV / EBITDA
- 8.93x
- EV / EBIT
- 10.05x
- Market cap
- $23.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026